Boston Scientific Statistics Share Statistics Boston Scientific has 1.48B
shares outstanding. The number of shares has increased by 0.46%
in one year.
Shares Outstanding 1.48B Shares Change (YoY) 0.46% Shares Change (QoQ) 0.03% Owned by Institutions (%) 89.02% Shares Floating 1.47B Failed to Deliver (FTD) Shares 114 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 19.57M, so 1.32% of the outstanding
shares have been sold short.
Short Interest 19.57M Short % of Shares Out 1.32% Short % of Float 1.33% Short Ratio (days to cover) 2.87
Valuation Ratios The PE ratio is 70.89 and the forward
PE ratio is 30.35.
Boston Scientific's PEG ratio is
4.28.
PE Ratio 70.89 Forward PE 30.35 PS Ratio 7.85 Forward PS 6.9 PB Ratio 6.04 P/FCF Ratio 49.69 PEG Ratio 4.28
Financial Ratio History Enterprise Valuation Boston Scientific has an Enterprise Value (EV) of 142.17B.
EV / Sales 8.49 EV / EBITDA 36.1 EV / EBIT 41.39 EV / FCF 53.75
Financial Position The company has a current ratio of 1.08,
with a Debt / Equity ratio of 0.51.
Current Ratio 1.08 Quick Ratio 0.64 Debt / Equity 0.51 Debt / EBITDA 2.83 Debt / FCF 4.21 Interest Coverage 6.81
Financial Efficiency Return on Equity is 8.52% and Return on Invested Capital is 6.13%.
Return on Equity 8.52% Return on Assets 4.71% Return on Invested Capital 6.13% Revenue Per Employee $315.98K Profits Per Employee $34.98K Employee Count 53,000 Asset Turnover 0.43 Inventory Turnover 2.31
Taxes Income Tax 436M Effective Tax Rate 19.11%
Stock Price Statistics The stock price has increased by 35.34% in the
last 52 weeks. The beta is 0.66, so Boston Scientific's
price volatility has been higher than the market average.
Beta 0.66 52-Week Price Change 35.34% 50-Day Moving Average 103.64 200-Day Moving Average 98.36 Relative Strength Index (RSI) 44.94 Average Volume (20 Days) 7,504,720
Income Statement In the last 12 months, Boston Scientific had revenue of 16.75B
and earned 1.85B
in profits. Earnings per share was 1.26.
Revenue 16.75B Gross Profit 10.27B Operating Income 2.63B Net Income 1.85B EBITDA 3.94B EBIT 2.67B Earnings Per Share (EPS) 1.26
Full Income Statement Balance Sheet The company has 414M in cash and 11.15B in
debt, giving a net cash position of -10.73B.
Cash & Cash Equivalents 414M Total Debt 11.15B Net Cash -10.73B Retained Earnings 2.67B Total Assets 40.14B Working Capital 2.28B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 3.44B
and capital expenditures -790M, giving a free cash flow of 2.65B.
Operating Cash Flow 3.44B Capital Expenditures -790M Free Cash Flow 2.65B FCF Per Share 1.8
Full Cash Flow Statement Margins Gross margin is 61.31%, with operating and profit margins of 15.73% and 11.07%.
Gross Margin 61.31% Operating Margin 15.73% Pretax Margin 13.63% Profit Margin 11.07% EBITDA Margin 23.51% EBIT Margin 15.73% FCF Margin 15.79%
Dividends & Yields BSX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 1.41% FCF Yield 2.01%
Dividend Details Analyst Forecast The average price target for BSX is $119,
which is 15.8% higher than the current price. The consensus rating is "Buy".
Price Target $119 Price Target Difference 15.8% Analyst Consensus Buy Analyst Count 22
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 20.48 Graham Upside -80.07%
Stock Splits The last stock split was on Nov 6, 2003. It was a
forward
split with a ratio of 2:1.
Last Split Date Nov 6, 2003 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 6.11 Piotroski F-Score 5
